Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses the findings from our collaborative research

courtneybennett

By Courtney Bennett

05/26/2020

Qi Liu, PhD, of the U.S. Food and Drug Administration, discusses data that suggest that patients with advanced non–small cell lung cancer who had a past medical history of pneumonitis were more likely to experience treatment-associated pneumonitis in response to immune checkpoint inhibitors or chemotherapy.

See the video here.